Background
==========

The proper assembly of basic proteins with nucleic acids, such as occurs in the packaging of histones with DNA to produce chromatin and in the packaging of ribosomal proteins with rRNA to form ribosomes, is a reaction that must be facilitated so as to prevent the aggregation of these oppositely charged groups of molecules. Proteins that mediate these reactions, generally termed molecular (or nuclear) chaperones, have been identified biochemically. Two well studied proteins that participate in the processes of chromatin and ribosome assembly are nucleoplasmin and nucleophosmin, respectively, two related proteins whose characteristic acidic domains have been shown to bind the basic proteins involved in these processes and present them to the nucleic acid.

Nucleoplasmin is the most abundant protein in the *Xenopus* oocyte nucleus and is the protein for which the term molecular chaperone was coined due to its multiple roles in the assembly of nucleosomes during early frog development \[[@B1]\]. Nucleoplasmin forms a pentamer and its stretches of acidic residues bind to histone H2A and H2B. In concert with the unrelated acidic protein N1/N2, which binds histones H3 and H4, they act together and with other factors to assemble nucleosomes \[[@B2],[@B3]\]. In addition to assembly, nucleoplasmin and other proteins are involved in the chromatin remodeling and nucleosome disassembly that occurs, for example, during transcription to allow the access of transcription factors to nucleosomal DNA \[[@B4]\]. Another major function of nucleoplasmin is the decondensation of sperm chromatin at fertilization. In this case, nucleoplasmin acts to exchange the sperm specific basic proteins, which allow the dense packing of DNA in sperm, with the histones H2A and H2B, thus effecting chromatin decondensation \[[@B5],[@B6]\]. Phosphorylation of nucleoplasmin appears to be important in regulating this activity, as heavily phosphorylated nucleoplasmin is significantly more active \[[@B7]\].

Nucleophosmin (also called B23 \[[@B8]\], NO38 \[[@B9]\] or numatrin \[[@B10]\]), a protein related to nucleoplasmin, is implicated in ribosome assembly due to its abundance, localization in the nucleolus and its multiple activities that are consistent with such a function. Some of these activities include nucleic acid binding \[[@B11]\], ribonuclease activity (for processing preribosomal RNA) \[[@B12]\] and association with maturing preribosomal ribonucleoprotein particles \[[@B13],[@B14]\]. It may also be involved in the transport of ribosomal or other nucleosomal proteins across the nuclear membrane, as it is known to shuttle between the cytoplasm and nucleus and to stimulate the nuclear importation of proteins \[[@B15],[@B16]\]. Nucleophosmin also appears to be intimately involved in centrosome duplication. It associates specifically with unduplicated centrosomes, and its phosphorylation by CDK-2/cyclin E, the trigger for centrosome duplication, is required for duplication to occur \[[@B17]\]. The nucleophosmin gene is also known for its fusion with the anaplastic lymphoma kinase *(ALK)* receptor tyrosine kinase in cases of this disease with (2;5)(p23;q35) translocations \[[@B18]\]. The nucleophosmin portion contributes to transformation by providing a dimerization domain, which allows activation of the fused kinase and signal transduction \[[@B19]\].

We previously discovered and initially characterized a novel member of this family in the mouse, namely nucleophosmin/nucleoplasmin 3 (*Npm3*). To identify the human ortholog of *Npm3* and begin its characterization, we have cloned a human *NPM3* cDNA, determined its genomic structure and relationship to other family members and show its expression in multiple tissues and subcellular localization in the nucleus.

Results and Discussion
======================

*NPM3* cDNA cloning and genomic structure
-----------------------------------------

Mouse *Npm3* is located approximately 5 kb upstream of the *Fgf8* gene in the same transcriptional orientation \[[@B20],[@B21]\]. To determine if human *NPM3* is similarly located and to identify genomic clones of *NPM3,* we analyzed FGF8-containing human genomic lambda clones \[[@B22]\] by Southern blotting using a mouse *Npm3* cDNA probe. A 4.3-kb *Hin*d III-*Xho* I fragment that hybridized to *Npm3* was identified, subcloned and used to screen a human liver cDNA library. Several partial cDNAs with strong sequence homology to mouse *Npm3* were isolated. The 5\' coding region was subsequently isolated using a reverse transcriptase-PCR approach and was fused to one of the partial cDNAs at a common restriction site to produce a cDNA with full coding potential. Sequencing of subcloned genomic fragments and comparison with the cDNA sequence allowed us to construct an exon map of the *NPM3* gene (Figure [1A](#F1){ref-type="fig"}). *NPM3* has the same exon structure as the mouse ortholog and is located approximately 5.5 kb upstream of *FGF8,* in the same transcriptional orientation (Figure [1B](#F1){ref-type="fig"}). The *NPM3* exon/intron boundaries and organization information is presented in Table [1](#T1){ref-type="table"}. Based on its close linkage to *FGF8, NPM3* maps to chromosome 10q24-26 \[[@B23],[@B24]\].

![***NPM3* genomic structure and linkage to *FGF8.*** (A) Genomic structure of *NPM3.* Boxed areas represent *NPM3* exons. The yellow and black shadings represent translated and untranslated regions, respectively. (B) Linkage of *NPM3* to *FGF8.* The location of genes and restriction map were determined by a combination of sequencing and restriction mapping of lambda clones and subclones in this study and a previous study \[[@B22]\]. An *NPM3* cDNA probe will hybridize to restriction fragments of the following sizes in human genomic DNA: *Avr* II, 0.4 and 3.9 kb; *Bam* H I, 1.6 and 6.0 kb; *Eco* R V, 7.2 kb; *Hind* III, 6.8 kb; *Kpn* I, 6.6 kb; *Sac* I, 1.6 and 4.0 kb; *Sma* I, 1.0 and 5.1 kb; *Stu* I, 2.6 and 14.1 kb;*Xho* I, 8.4 kb. Restriction enzyme abbreviations: A, *Avr* II; B, *Bam* H I; H, *Hind* III; K, *Kpn* I; RV, *Eco* R V; N, *Not* I; S, *Sac* I; Sm, *Sma* I; St, *Stu* I; Xh, *Xho* I.](1471-2164-2-8-1){#F1}

###### 

Exon/intron organization of the *NPM3* gene

  Exon no.   Exon size (bp)   5\' Splice site^\*^   Intron size (bp)   3\' Splice site^\*^   Exon no.       Amino acid at splice^\*\*^       
  ---------- ---------------- --------------------- ------------------ --------------------- -------------- ---------------------------- --- ------
  1          133              GTTTTTTCTTCG          gtattagtgaag       348                   tatttctaccag   GCTGTGAGCTCT                 2   G40
  2          87               GCACTAACCATG          gtgaggggcagg       241                   taccgttcccag   CTCTGCCTCACC                 3   M68
  3          120              TGCCAACCCATG          gtgagttcccca       126                   tcttcctcccag   CTCAGTCTGGAT                 4   M108
  4          94               GGCACCAGATTG          gtgagaagaggg       403                   tgtgtccaccag   TTACGATGAGCA                 5   V140
  5          128              TAGCCCTCCTAG          gtgagttgcggg       94                    tcctcttttcag   GTCAGCTCCATG                 6   None
  6          308                                                                                                                             

^\*^Exon bases are capitalized; intron bases are in lower case. ^\*\*^The amino acid codon that is split by, or located immediately before, the splice site is denoted.

*NPM3* sequence analysis
------------------------

The amino acid sequence deduced from the human *NPM3* cDNA sequence was 87% identical and 95% similar to mouse *Npm3* (Figure [2](#F2){ref-type="fig"}). The human sequence is three amino acids longer than that of the mouse; these additional residues lie in the acidic domain in the C-terminal portion of the protein. At least eight potential serine and threonine phosphorylation sites are present in the human protein involving such kinases as casein kinase I and II, protein kinase A and C, glycogen synthase kinase 3 and calmodulin-dependent protein kinase II (Figure [2](#F2){ref-type="fig"}). All of these consensus sites are also found in mouse Npm3 with the exception of the casein kinase I site at residue 16. A cluster of amino acids at the C-terminus that is rich in basic residues and glycines forms a potential nuclear localization signal \[[@B25],[@B26]\] in the human as well as the mouse protein (Figure [2](#F2){ref-type="fig"}). Multiple phosphorylation sites and nuclear localization signals, or the ability to bind proteins with such signals, are also characteristics of nucleophosmin and nucleoplasmin \[[@B16],[@B27]-[@B29]\]. When the functions of NPM3 are elucidated, it will be of interest to determine the contribution of phosphorylation to these activities, since the functions of both nucleoplasmin and nucleophosmin are regulated by phosphorylation, which is extensive in both proteins \[[@B7],[@B17]\]).

![**Comparison and features of human NPM3 and mouse Npm3 amino acid sequences.** Identical amino acids are denoted by an asterisk, highly similar residues by a colon and less similar residues by a period, as determined by CLUSTAL W software. The putative nuclear localization signal is overlined. Potential phosphorylation sites in NPM3 for the indicated kinases are shown, as predicted by NetPhos 2.0. Arrows denote splice points in the mRNA. Dashes represent gaps in the alignment. Kinase abbreviations: CKI, casein kinase I; CKII, casein kinase II; CaMII, calmodulin-dependent protein kinase II; GSK3, glycogen synthase kinase 3; PKA, protein kinase A; PKC, protein kinase C.](1471-2164-2-8-2){#F2}

To enable an amino acid comparison between NPM3 with other members of the nucleophosmin/nucleoplasmin family, we searched the nonredundant GenBank database using human NPM3, *Xenopus* nucleoplasmin and human nucleophosmin as BLASTP queries, and 11 additional full-length proteins were retrieved (Table [2](#T2){ref-type="table"}). An amino acid comparison of NPM3 with these other members of the nucleophosmin/nucleoplasmin family from various metazoans reveals extensive sequence identities and similarities throughout all of NPM3 except the C-terminal 16 residues (Figure [3](#F3){ref-type="fig"}). All members of this family have a core region of relatively close similarity in the N-terminal half of the proteins. C-terminal to this region, all have one or more acidic domains consisting of a total of 17 to more than 100 aspartic acid and glutamic acid residues per molecule. These two residues can comprise more than 25% of the total amino acids in some proteins of this family; in NPM3 they make up approximately 18% of the residues. The N-terminal core region of high similarity between family members correlates to a region in nucleophosmin/B23 that has been shown to be involved in oligomerization as well as chaperone activity \[[@B44]\]. A central portion between nucleophosmin\'s two acidic domains is required for ribonuclease activity \[[@B44]\]; this region does not have a corresponding domain in either NPM3 or nucleoplasmin, suggesting that these proteins would lack such activity. A nucleic acid binding domain in the C-terminus of nucleophosmin is also lacking in NPM3 and nucleoplasmin, but the known functions of nucleoplasmin in nucleosome assembly and sperm decondensation suggest that this protein, and possibly NPM3, can accomplish intermolecular reactions involving nucleic acids in other ways, perhaps by associating with other proteins that have this binding activity. Indeed, NO29, a *Xenopus* protein with significant si milarity to NPM3, is found to associate with NO38, the *Xenopus* ortholog of mammalian nucleophosmin \[[@B43]\].

![**A comparison of nucleophosmin/nucleoplasmin family members from metazoans.** The alignment was made with CLUSTAL W. Aligned residues that were identical or similar in at least 50% of the sequences, excluding gaps, were shaded with a black or gray background, respectively; additionally, any residues that were similar to a block of identical residues were shaded in gray. Similar amino acids were grouped as follows: I, L, M, V; F, W, Y; H, K, R; D, E; N, Q; A, G; S, T; P; C. The names, species, accession numbers and references for these sequences are presented in Table [2](#T2){ref-type="table"}.](1471-2164-2-8-3){#F3}

###### 

Accession numbers of amino acid sequences

  Symbol^\*^   Name(s)                                     Species                     Accession No.   Ref. No.
  ------------ ------------------------------------------- --------------------------- --------------- ------------
  NUPL-X1      Nucleoplasmin                               *Xenopus laevis*            CAA28460        \[[@B34]\]
  NUPL-A-X1    Nucleoplasmin A                             *Xenopus laevis*            CAA68363        \[[@B31]\]
  Npm3-mm      Nucleophosmin/nucleoplasmin-3               *Mus musculus*              NP_032749       \[[@B21]\]
  NPM3-Hs      Nucleophosmin/nucleoplasmin-3               *Homo sapiens*              AY049737        this study
  NO29-X1      NO29; NOVA                                  *Xenopus laevis*            CAB06652        \[[@B43]\]
  NPM-Mm       Nucleophosmin; NO38; B23; Numatrin          *Mus musculus*              NP_032748       \[[@B40]\]
  NPM-Rn       Nucleophosmin; NO38; B23; Numatrin          *Rattus norvegicus*         P13084          \[[@B33]\]
  NPM-Hs       Nucleophosmin; NO38; B23; Numatrin          *Homo sapiens*              NP_002511       \[[@B32]\]
  NPM-Gg       Nucleophosmin; NO38; B23; Numatrin          *Gallus gallus*             P16039          \[[@B37]\]
  NPM-X1       Nucleophosmin; NO38; B23; Numatrin          *Xenopus laevis*            A41730          \[[@B39]\]
  NAAP36-Ap    Nucleic acid-associated protein 36; ANO39   *Asterina pectinifera*      BAA90827        \[[@B38]\]
  MP62-Lp      Mitotic apparatus protein p62               *Lytechinus pictus*         P91753          \[[@B42]\]
  DNLP-Dm      Nucleoplasmin-like protein                  *Drosophila melanogaster*   Q27415          \[[@B35]\]
  CG7911-Dm    CG7911 gene product                         *Drosophila melanogaster*   AAF56987        \[[@B30]\]
  N1/N2-X1     Nuclear histone-binding protein N1/N2       *Xenopus laevis*            A25680          \[[@B36]\]
  NASP-Hs      Nuclear autoantigenic sperm protein         *Homo sapiens*              NP_002473       \[[@B41]\]

^\*^Symbol as used in this study

To gain further insight into the relationship of NPM3 with the other known members of this family, we used CLUSTAL W and TreeTop \[[@B45]\] to produce a dendrogram of these relationships (Figure [4](#F4){ref-type="fig"}). In this analysis, we included the 14 proteins from Figure [3](#F3){ref-type="fig"} together with two other histone-binding proteins that are unrelated to this family. These two proteins, *Xenopus* N1/N2 \[[@B36]\] and human NASP (nuclear autoantigenic sperm protein) \[[@B41]\], are closely related to each other and may be orthologs \[[@B46]\]. This analysis shows that NPM3 is more closely related to NO29 and the nucleoplasmins from *Xenopus* than to the nucleophosmins from multiple species. No nucleoplasmin ortholog in humans has been reported to date, and our screening of GenBank has not detected such a sequence. The relationship between N1/N2 and NASP can be seen in this dendrogram and appears similar in closeness to that of NPM3 and NO29. The kinship of NPM3 and NO29 is supported by recent GenBank screens with the NPM3 amino acid sequence as a TBLASTN query against the entire nonredundant GenBank database, which resulted in NO29 sequences as the best non-NPM3 match, and vice versa. Although other genomic and functional studies would be required to prove an orthologous relationship between NPM3 and NO29, they appear by several analyses to share a relatively close evolutionary history and as such could be considered candidate orthologs.

![**Dendrogram of nucleophosmin/nucleoplasmin family members.** Amino acid sequences from the 16 proteins shown were aligned with CLUSTAL W, and a dendrogram was produced using the TreeTop algorithm as described in Materials and Methods. The 16 sequences included 14 from the nucleophosmin/nucleoplasmin family (see Table [2](#T2){ref-type="table"} and Figure [3](#F3){ref-type="fig"}) and two other histone-binding proteins (NASP and N1/N2), which are closely related to each other but unrelated to the nucleophosmin/nucleoplasmin family. Bootstrap significance values are shown at the branchpoints for 100 resamplings. The analysis suggests that NPM3 is more related to nucleoplasmins than to nucleophosmins and that NPM3 is closely related to *Xenopus* NO29.](1471-2164-2-8-4){#F4}

NPM3 expression in human tissues
--------------------------------

We examined the expression of *NPM3* in 16 human tissues by Northern blot analysis (Figure [5](#F5){ref-type="fig"}). Abundant and relatively equal expression of *NPM3* was found in all tissues with the highest levels, relative to actin, in pancreas and testis and the lowest in lung. Previous analysis of *Npm3* expression in mouse tissues also showed generally equal and strong expression in the tissues tested with especially strong expression in testis \[[@B21]\]. However, in the mouse, the brain, rather than the lung, displayed the lowest *Npm3* RNA levels. Nevertheless, the widespread and relatively strong expression of the gene in both species suggests that the protein has a fundamental function(s) in cells of many, if not all, tissues. The apparently ubiquitous expression and abundant levels of *NPM3* RNA are consistent with other members of this gene family and with a proposed role as a molecular chaperone.

![**Northern blot expression analysis of *NPM3* in human tissues.** Upper panels, hybridization with the human *NPM3* cDNA probe. Lower panels, hybridization with the mouse beta-actin cDNA probe. The location of the molecular weight standards in kb is indicated to the left of the blots.](1471-2164-2-8-5){#F5}

NPM3 protein localizes to the nucleus
-------------------------------------

All of the nucleophosmin and nucleoplasmin homologs that have been studied to date are localized in the nucleus. To allow a determination of the subcellular localization of the NPM3 protein, we tagged the protein at its N-terminus with a hemagglutinin (HA) epitope. We then expressed this protein in NIH3T3 cells, fractionated the cells into nuclear, cytoplasmic and extracellular (culture medium) fractions and analyzed these by immunoblotting using an anti-HA antibody. This analysis revealed that NPM3 was localized only in the nuclear fraction (Figure [6](#F6){ref-type="fig"}). The NPM3 protein migrated in SDS-PAGE gels as a doublet with apparent molecular masses of 25 and 27 kDa, which are larger than the 20.5 kDa mass predicted by the deduced amino acid sequence including the HA tag. Similarly, other members of the nucleophosmin/nucleoplasmin family also migrate more slowly than expected: *Xenopus* NO29 migrates at 29 kDa versus the expected 20 kDa \[[@B44]\], *Xenopus* NO38 migrates at 38 kDa versus the expected 33.5 kDa \[[@B9]\], and *Xenopus* nucleoplasmin migrates at 38 kDa rather than 33.5 kDa \[[@B9]\]. The slower migration is likely primarily due to an electrophoretic anomaly reflecting the amino acid composition, although phosphorylation or other modifications could conceivably contribute. Supporting this notion, the *in vitro* transcription/translation of a plasmid encoding the closely related NO29 protein produces a product, presumably unmodified, with slow mobility that is similar to the mobility of NO29 extracted from cells \[[@B43]\]. The smaller-sized polypeptide of the NPM3 doublet is probably a degradation product, as is observed in analyses of the NO29 protein \[[@B43]\]. This subcellular localization of NPM3, together with the other results here, suggests that this protein is a molecu lar chaperone with functions in the nucleus.

![**Immunoblot analysis of the cellular localization of HA-tagged NPM3.** Protein samples (50 mg) were subjected to SDS-PAGE, electrophoretic transfer to nitrocellulose and immunoblotting with an anti-HA antibody. Media, cytoplasm and nucleus are the subcellular fractions analyzed. The locations of the molecular weight standards in kDa are indicated to the left of the blot. Arrows indicate bands associated with HA-tagged NPM3. (A) cells mock-transfected; (B) cells transfected with antisense HA-tagged *NPM3* cDNA construct; (C) cells transfected with sense HA-tagged *NPM3* cDNA construct.](1471-2164-2-8-6){#F6}

Conclusions
===========

The striking similarities in amino acid sequence and domain structure between NPM3 and its chaperone relatives, nucleophosmin and nucleoplasmin, together with abundant expression levels and nuclear localization, strongly suggests that NPM3 shares fundamental nuclear chaperone functions with these proteins. It will be important in future work to refine these results and test, for example, whether NPM3 may have chromatin or ribosome assembly functions that are similar or complementary to nucleoplasmin or nucleophosmin, or whether it may have completely independent functions.

Materials and methods
=====================

Isolation of *NPM3* genomic probes
----------------------------------

We digested previously isolated lambda genomic clones of the human *FGF8* region \[[@B22]\] with restriction endonucleases (Promega, Madison, WI) and analyzed them by Southern blotting using a mouse *Npm3* cDNA \[[@B21]\] probe, as previously described \[[@B20]\]. An 8.4-kb *Xho* I fragment from these clones that hybridized to the probe was subcloned into pBluescript (Stratagene) for analysis. Deletion of *non-Npm3* sequences from this clone resulted in a 4.3-kb *Hin*d III-*Xho* I fragment, which was then isolated and used as a probe for the isolation of a human *NPM3* cDNA.

Isolation of *NPM3* cDNA
------------------------

The 4.3-kb *Hin*d III-*Xho* I human genomic fragment described above was used as a probe to screen a λgt11 human liver cDNA library for the *NPM3* cDNA. Three positive clones were obtained from 250,000 plaques. Following isolation of pure plaques, the insert DNAs were prepared by PCR methods with the following conditions: 100 μl reactions containing 1X *Pfu* buffer (20 mM Tris-Cl, pH 8.75, 10 mM KCl, 2 mM MgSO~4~, 10 mM (NH~4~)~2~SO~4~, 0.1% v/v Triton X-100, 100 μg/ml bovine serum albumin), 1 μM λgt11 forward and reverse primers (Promega, Madison, WI), 0.2 mM deoxyribonucleotides, and 5 Units of recombinant *Pfu* DNA Polymerase (Stratagene, La Jolla, CA). The thermocycling conditions were as follows: 95°C for 3 minutes, then 30 cycles of 95°C for 45 seconds, 50°C for 30 seconds and 75°C for 60 seconds, then 75°C for 10 minutes, using a PTC-100 Thermocycler (M.J. Research, Watertown, MA). The resulting cDNA inserts were purified by agarose gel electrophoresis, digested with *Eco*R I and cloned into pBluescript KS- (Stratagene, La Jolla, CA). The cDNA inserts were thermocycle-sequenced using the *fmol* kit (Promega, Madison, WI) and found to be identical and to lack a portion of the 5\' coding region.

To obtain the 5\' end of the *NPM3* cDNA, we performed 5\' Rapid Amplification of cDNA Ends (RACE), using a Marathon-Ready™ human testis cDNA library (Clontech, Palo Alto, CA) and the Marathon™ cDNA amplification kit (Clontech, Palo Alto, CA). The RACE conditions were as follows: 50 μl reactions containing 1X KlenTaq buffer and Advantage KlenTaq Polymerase Mix (Clontech, Palo Alto, CA), 0.2 mM deoxyribonucleotides, 0.2 μM *NPM3* GSP1 (5\'-CGG TGA GGC AGA GCA TGG TTA GTG C-3\'), and 0.2 μM API primer (Clontech, Palo Alto, CA). Touchdown PCR conditions were employed as follows: 95°C for 5 minutes, then 5 cycles of 95°C for 10 seconds, 72°C for 2 minutes, then 5 cycles of 95°C for 10 seconds, 70°C for 2 minutes, then 25 cycles of 95°C for 10 seconds, 68°C for 2 minutes. The resulting band was purified by agarose gel electrophoresis and subcloned into pCR II (Invitrogen, Carlsbad, CA). Multiple clones were thermocycle sequenced to confirm the 5\' sequence of human *NPM3* cDNA. Finally, to produce a full-length human *NPM3* cDNA, we spliced together the 5\' RACE *NPM3* cDNA with the original partial cDNA obtained from the lambda library at a unique *Sac* I site present in both fragments. The final cDNA sequence was submitted to GenBank (accession number AY049737).

Determination of exon structure
-------------------------------

Fragments of the 4.3-kb *Hin*d III-*Xho* I *NPM3* genomic DNA isolated above that hybridized to a mouse *Npm3* cDNA probe were further subcloned into pBS and sequenced using an automated ABI 377 sequencer. Comparison of these compiled sequences with the human *NPM3* cDNA sequence allowed the localization of exon sequences within the genomic DNA. The genomic sequence and exon placement was later confirmed with human genome sequences that subsequently appeared in GenBank (accession number AC010789).

Sequence analysis
-----------------

Amino acid sequences were aligned using CLUSTAL W (v. 1.81) with default parameters on a European Molecular Biology Laboratory web server <http://www.ebi.ac.uk>. An alignment output from this source was used to create a dendrogram using TreeTop \[[@B45]\] with PHYLIP output (default parameters) at a node of the European Molecular Biology Network <http://www.genebee.msu.su>\[[@B47]\]. Potential phosphorylation sites were identified using NetPhos 2.0 <http://www.cbs.dtu.dk/services/NetPhos>\[[@B48]\]. After alignment with CLUSTAL W, identical and similar amino acids in Figure [3](#F3){ref-type="fig"} were identified using MacBoxshade 2.15 <http://www.isrec.isb-sib.ch/ftp-server/boxshade/MacBoxshade>.

Northern blot analysis
----------------------

Human tissue northern blots of poly(A)^+^ RNA were obtained from Clontech (Palo Alto, CA) and sequentially hybridized with radiolabeled *NPM3* cDNA and beta-actin probes as previously described \[[@B20]\].

Hemagglutinin-tagged NPM3
-------------------------

A cDNA that encodes a hemagglutinin-tagged NPM3 protein was produced by PCR under the following conditions: 100 μl reactions with 1X *Pfu* buffer, 0.2 mM deoxyribonucleotides, 1 μM HA-F primer (5\'-AAA GAA TTC AGC ATG TAC CCA TAC GAC GTC CCA GAC TAC GCC GCC GCC GGT ACT GCA GCT GCC-3\'), 1 μM *NPM3*-R2 primer (5\'-AAA GAA TTC CTA GGG CCT GCC CCC CTG CTT TTT GGC AGG AAG GAT GGG-3\'), 1 ng of human *NPM3* cDNA insert, and 2.5 Units of recombinant *Pfu* DNA Polymerase. The thermocycling conditions were as follows: 95°C for 3 minutes, then 30 cycles of 95°C for 45 seconds, 75°C for 60 seconds, then 75°C for 10 minutes, using a PTC-100 Thermocycler (M.J. Research, Watertown, MA). The resulting DNA fragment was purified by agarose gel electrophoresis, cleaved with *Eco*R I, and subcloned into pBluescript KS-. The resulting plasmids were thermocycle sequenced, and an insert with the correct sequence was identified and subcloned into pMIRB \[[@B49]\]. The orientations of the resulting inserts were determined by restriction digests with *Sac* I.

Cellular localization of HA-NPM3 by cell fractionation and immunoblotting
-------------------------------------------------------------------------

The resulting pMIRB-HA-NPM3 plasmids (both sense and antisense orientations) were transiently transfected into NIH 3T3 cells, using transfection conditions with Lipofectamine and OptiMEM serum-free medium (Gibco-BRL, Bethesda, MD) as described \[[@B49]\]. Following a six-hour incubation of the DNA-Lipofectamine complexes in OptiMEM, the cells were washed and incubated in 10-cm dishes with their usual growth media (DMEM with 10% v/v fetal calf serum, 2 mM L-glutamine, 100 Units/ml of Penicillin G and 100 μg/ml Streptomycin) for 48--72 hours at 37°C in humidified 5% CO~2~ incubators.

Following the 48--72 hour incubation, the media was collected and placed on ice with the following protease inhibitors added: 1 mM DTT (Sigma, St. Louis, MO), 0.5 mM PMSF (Sigma, St. Louis, MO), 5 μg/ml Pepstatin (Sigma, St. Louis, MO), 3 μg/ml Leupeptin (Sigma, St. Louis, MO) and 5 μg/ml Aprotinin (Sigma, St. Louis, MO). The cells were washed 3X in cold PBS and collected by cell scrapers (Nunc) in 1 ml of cold PBS. The cells were transferred to microfuge tubes, pelleted (5 seconds at 14,000 rpm, Eppendorf 5415C, 4°C) and resuspended in hypotonic Buffer A (10 mM K-HEPES pH 7.9, 1.5 mM MgCl~2~, and 10 mM KCl, with inhibitors added as for the media above) for 15 minutes on ice. The suspension was vortexed vigorously for 10 seconds to lyse the cells, and then microcentrifuged (1 minute at 14,000 rpm, Eppendorf 5415C, 4°C). The resulting supernatant was called \"cytoplasm\" but actually contained cytoplasmic membranes as well. The resulting nuclear pellet was resuspended in 20 μl of Buffer C (20 mM K-HEPES pH 7.9, 1.5 mM MgCl~2~, 0.2 mM EDTA, 20% v/v glycerol, and 0.42 M NaCl, with protease inhibitors as above), incubated on ice for 20 minutes, then microcentrifuged (5 minutes at 14,000 rpm, Eppendorf 5415C, 4°C). This final supernatant was the nuclear extract.

The protein solutions were quantified by Bradford Assay (Biorad, Hercules, CA), and 50 mg of each sample were subjected to SDS-PAGE (15% acrylamide). Following electrophoresis, the gel contents were electrophoretically-transferred to nitrocellulose (500 mA, 60--90 V, 1 hour, 4°C, Transfer Buffer II from Harlow and Lane \[[@B50]\]). The membrane was blocked with 5% w/v nonfat dried milk in PBS-0.1% v/v Tween 20 (PBS-T) overnight at 4°C, then subjected to immunoblotting and ECL (Amersham, Arlington, IL) detection. The primary antibody was monoclonal mouse anti-hemagglutinin (dilution 1:1000 in PBS-T, gift of Guojon Bu, Washington University, St. Louis), and the secondary antisera was horseradish peroxidase-conjugated sheep anti-mouse IgG (dilution 1:1000 in PBS-T, Amersham, Arlington, IL).
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